About
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modelling, precision medicine, microbiome research, and compound screening.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 115 investors are based in Durham, North Carolina, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Durham, US
Contact Information
Find more investors like Altis
Search Investors